New technologies for biomarker discovery in multiple sclerosis

被引：2
|
作者：
Comabella, Manuel [1 ]
Racke, Michael K. [2 ]
机构：
[1] HUVH, Unitat Neuroimmunol Clin, Ctr Esclerosi Multiple Catalunya, CEM Cat, Barcelona, Spain
[2] Ohio State Univ, Dept Neurol & Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2012年 / 248卷 / 1-2期
关键词：
D O I：
10.1016/j.jneuroim.2012.05.018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [41] LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis
    Takahashi, Keita
    Tanaka, Fumiaki
    Takei, Kohtaro
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (06) : 469 - 472
  • [42] Spinal cord anterior horn atrophy: a new biomarker in progressive multiple sclerosis
    Tsagkas, C.
    Horvath, A.
    Haas, T.
    Cagol, A.
    Amann, M.
    Barakovic, M.
    Ruberte, E.
    Weigel, M.
    Pezold, S.
    Schlaeger, R.
    Sprenger, T.
    Kappos, L.
    Bieri, O.
    Cattin, P.
    Granziera, C.
    Parmar, K.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 393 - 394
  • [43] Discovery of multiple sclerosis: Nosographic reasoning
    Bouchard, JP
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1998, 89 (04): : 284 - 284
  • [44] GFAP in early multiple sclerosis: A biomarker for inflammation
    Kassubek, Rebecca
    Gorges, Martin
    Schocke, Michael
    Hagenston, Viktoria A. M.
    Huss, Andre
    Ludolph, Albert C.
    Kassubek, Jan
    Tumani, Hayrettin
    NEUROSCIENCE LETTERS, 2017, 657 : 166 - 170
  • [45] Endocan, novel potential biomarker for multiple sclerosis?
    Akil, E.
    Alp, R.
    Ozdemir, H. H.
    Arslan, D.
    Cevik, M. U.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 192 - 192
  • [46] MCAM in Multiple Sclerosis: a biomarker of disease activity?
    Muccilli, Alexandra
    Charabati, Marc
    Michel, Laure
    Bourbonniere, Lyne
    Larochelle, Catherine
    Prat, Alexandre
    NEUROLOGY, 2017, 88
  • [47] Metabolic profiling technologies for biomarker discovery in biomedicine and drug development
    Schlotterbeck, Goetz
    Ross, Alfted
    Dieterle, Frank
    Senn, Hans
    PHARMACOGENOMICS, 2006, 7 (07) : 1055 - 1075
  • [48] Application of 'omics technologies to biomarker discovery in inflammatory lung diseases
    Wheelock, Craig E.
    Goss, Victoria M.
    Balgoma, David
    Nicholas, Ben
    Brandsma, Joost
    Skipp, Paul J.
    Snowden, Stuart
    Burg, Dominic
    D'Amico, Arnaldo
    Horvath, Ildiko
    Chaiboonchoe, Amphun
    Ahmed, Hassan
    Ballereau, Stephane
    Rossios, Christos
    Chung, Kian Fan
    Montuschi, Paolo
    Fowler, Stephen J.
    Adcock, Ian M.
    Postle, Anthony D.
    Dahlen, Sven-Erik
    Rowe, Anthony
    Sterk, Peter J.
    Auffray, Charles
    Djukanovic, Ratko
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) : 802 - 825
  • [49] Serum neurofilament level as a biomarker in multiple sclerosis
    Jabbar, Huda Qate'a
    Hassoun, Hayder K.
    Allebban, Zuhair
    NEUROLOGY ASIA, 2024, 29 (01) : 183 - 191
  • [50] a circulating biomarker for therapeutic response in multiple sclerosis
    Nayak, R.
    Vollmer, T.
    Bomprezzi, R.
    Jacolik, R.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S462 - S462
12345